secwatch.observer — SEC 8-K summary
======================================

Issuer:     CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK:        0001087294
Form:       8-K
Filed at:   2024-03-20T23:59:59+00:00
Accession:  0001628280-24-012261
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cumberland Pharmaceuticals launches $5.8M at-the-market equity offering with H.C. Wainwright
--------------------------------------------------------------------------------

- ATM program filed March 20, 2024 for up to $5.8M of common stock through H.C. Wainwright as sales agent.
- Sales agent will receive 3.0% commission on gross proceeds from shares sold under the agreement.
- Proceeds intended for working capital, R&D expenses, capital expenditures, and general corporate purposes.
- Sales may occur at prevailing market prices; company may set minimum price or suspend offering at any time.
- Offering terminates upon sale of all shares or termination of agreement by either party on five days' notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1087294/000162828024012261/0001628280-24-012261-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1087294/000162828024012261/cpix-20240320.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-012261

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer